BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17888048)

  • 1. Development of parapneumonic empyema in children.
    Lahti E; Peltola V; Virkki R; Alanen M; Ruuskanen O
    Acta Paediatr; 2007 Nov; 96(11):1686-92. PubMed ID: 17888048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
    Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children.
    Lin CJ; Chen PY; Huang FL; Lee T; Chi CS; Lin CY
    J Microbiol Immunol Infect; 2006 Dec; 39(6):489-95. PubMed ID: 17164952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parapneumonic empyema in children before the era of pneumococcal vaccination.
    Niemi E; Korppi M
    Acta Paediatr; 2011 Sep; 100(9):1230-3. PubMed ID: 21443529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Empyema and pleural effusion in children].
    Arancibia MF; Vega-Briceño LE; Pizarro ME; Pulgar D; Holmgren N; Bertrand P; Rodríguez JL; Sánchez I
    Rev Chilena Infectol; 2007 Dec; 24(6):454-61. PubMed ID: 18180820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology and clinical characteristics of childhood parapneumonic empyemas].
    Desrumaux A; François P; Pascal C; Cans C; Croizé J; Gout JP; Pin I
    Arch Pediatr; 2007 Nov; 14(11):1298-303. PubMed ID: 17631988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric parapneumonic empyema: risk factors, clinical characteristics, microbiology, and management.
    Grisaru-Soen G; Eisenstadt M; Paret G; Schwartz D; Keller N; Nagar H; Reif S
    Pediatr Emerg Care; 2013 Apr; 29(4):425-9. PubMed ID: 23528501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine.
    Goldbart AD; Leibovitz E; Porat N; Givon-Lavi N; Drukmann I; Tal A; Greenberg D
    Scand J Infect Dis; 2009; 41(3):182-7. PubMed ID: 19117244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procoagulant activity in children with community acquired pneumonia, pleural effusion and empyema.
    Michelin E; Snijders D; Conte S; Dalla Via P; Tagliaferro T; Da Dalt L; Monciotti CM; Simioni P; Stefanutti G; Ghirardo V; Gamba P; Barbato A
    Pediatr Pulmonol; 2008 May; 43(5):472-5. PubMed ID: 18383331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pneumonia with empyema during varicella].
    Boutin A; Bosdure E; Schott A; Beydon N; Chabrol B; Dubus JC
    Arch Pediatr; 2008 Nov; 15(11):1643-7. PubMed ID: 18835141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complicated parapneumonic effusion and empyema in children.
    Shen YH; Hwang KP; Niu CK
    J Microbiol Immunol Infect; 2006 Dec; 39(6):483-8. PubMed ID: 17164951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based incidence of severe pneumonia in children in Kiel, Germany.
    Weigl JA; Puppe W; Belke O; Neusüss J; Bagci F; Schmitt HJ
    Klin Padiatr; 2005; 217(4):211-9. PubMed ID: 16032546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological study on childhood empyema in south eastern Nigeria.
    Asindi AA; Efem SE; Asuquo ME
    East Afr Med J; 1992 Feb; 69(2):78-82. PubMed ID: 1505392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
    Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
    Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors, microbiology and outcome of patients with parapneumonic effusion.
    Falguera M; Carratalà J; Bielsa S; García-Vidal C; Ruiz-González A; Chica I; Gudiol F; Porcel JM
    Eur Respir J; 2011 Nov; 38(5):1173-9. PubMed ID: 21565916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ready for the frontline: is early thoracoscopic decortication the new standard of care for advanced pneumonia with empyema?
    Suchar AM; Zureikat AH; Glynn L; Statter MB; Lee J; Liu DC
    Am Surg; 2006 Aug; 72(8):688-92; discussion 692-3. PubMed ID: 16913311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.
    Byington CL; Spencer LY; Johnson TA; Pavia AT; Allen D; Mason EO; Kaplan S; Carroll KC; Daly JA; Christenson JC; Samore MH
    Clin Infect Dis; 2002 Feb; 34(4):434-40. PubMed ID: 11797168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study.
    Langley JM; Kellner JD; Solomon N; Robinson JL; Le Saux N; McDonald J; Ulloa-Gutierrez R; Tan B; Allen U; Dobson S; Joudrey H
    BMC Infect Dis; 2008 Sep; 8():129. PubMed ID: 18816409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired pneumonia (CAP) in children in Oslo, Norway.
    Senstad AC; Surén P; Brauteset L; Eriksson JR; Høiby EA; Wathne KO
    Acta Paediatr; 2009 Feb; 98(2):332-6. PubMed ID: 19006533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.